Lisuride a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis - Hofmann, C; Penner, U; Dorow, R (Clin Neuropharmacol, 2002)
et al.